Postdoctoral Grant
An In-vivo Genome Wide Screen and Validation for Influenza A Virus Host Determinant Factors
Awarded in
2025
The project, An In-vivo Genome Wide Screen and Validation for Influenza A Virus Host Determinant Factors, led by research associate Chris Gelbmann, MD, PhD, aims to identify the host cell factors that allow Influenza A virus to replicate and cause disease. Using a novel in-vivo genome-wide screening approach, the study will reveal how the virus interacts with host cells in a living organism. These discoveries will help uncover new therapeutic targets to combat the overall health burden of this infection. Andrew Mehle, PhD, professor, Department of Medical Microbiology and Immunology, UW–Madison, serves as the supervising mentor.
